Planas 2012.

Study characteristics
Methods	Evaluation of diabetes management program using selected HEDIS measures Patient RCT, conducted in a regional community pharmacy chain in Tulsa, Oklahoma, USA Two arms: 1. Control group (control arm) and 2. Intervention group (intervention arm)
Participants	Control arm N: 27 Intervention arm N: 38 Diabetes type: unclear/not reported Mean age: NR ± NR % Male: NR Longest follow‐up: 9 months
Interventions	Control arm: 1) Patient education 2) Promotion of self‐management Intervention arm: 1) Case management 2) Team changes 3) Clinician education 4) Patient education 5) Promotion of self‐management
Outcomes	1) HbA1c, mean % (SD) Control arm: pre 7.8 (1.0), post 7.9 (0.9) Intervention arm: pre 7.6 (1.0), post 7.1 (1.0) 2) SBP, mean mmHg (SD) Control arm: pre 141.1 (24.9), post 140.2 (20.0) Intervention arm: pre 139.2 (17.9), post 124.0 (16.9) 3) DBP, mean mmHg (SD) Control arm: pre 75.3 (12.6), post 74.9 (10.3) Intervention arm: pre 78.1 (10.3), post 73.7 (9.9) 4) LDL, mean mg/dL (SD) Control arm: pre 94.4 (38.2), post 90.5 (31.3) Intervention arm: pre 109.3 (36.8), post 97.3 (24.1) 5) Controlled hypertension (< 130/80 mmHg), N under control (%) Control arm: pre 5 (23), post 5 (23) Intervention arm: pre 6 (20), post 16 (53)
Funding source	American Society of Health‐System Pharmacists Research and Education Foundation, the American Pharmacists Association Foundation, and USA Drug Stores
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	Previously generated random number list.
Allocation concealment (selection bias)	Unclear risk	Not reported.
Patient's baseline characteristics (selection bias)	Low risk	BMI (P < 0.05); all other characteristics were similar between groups.
Patient's baseline outcomes (selection bias)	Unclear risk	Not reported in text or table.
Incomplete outcome data (attrition bias)	High risk	Large losses from both arms, reasons not provided.
Blinding of participants and personnel (performance bias) and of outcome assessors (detection bias)	Low risk	Primary outcome: BP, using a aneroid sphygmomanometers at resting for period of 5 minutes. HbA1c measured using fingerstick DCA 2000, LDL using fingerstick Cholestech LDX, point of care after fasting for 9 to 12 hours.
Selective reporting (reporting bias)	Low risk	< 2005 approach used since no protocol; methods match results.
Risk of contamination (other bias)	Low risk	Information not available.
Other bias	Low risk	No evidence of other bias.